EATONTOWN, N.J., March 4, 2020 /PRNewswire/ -- Caregility, a clinical collaboration and communications company focused on providing secure, reliable two-way audio and video communications in both i

PHILADELPHIA, March 4, 2020 /PRNewswire/ -- HealthVerity, the trusted technology partner to the life sciences and insurance industries, announced today the expansion of its healthcare data ecosystem to include the most comprehensive set of closed pharmacy and medical payer data available in the market. The addition of multiple payer-oriented data sources to HealthVe

BRIDGEWATER, N.J., March 4, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced publication of results from a survey of patients with refractory Mycobacterium avium complex (MAC) lung disease on the clinical management of resp

NEW YORK, March 4, 2020 /PRNewswire/ -- Eight Sleep, the world's first sleep fitness company, today announced its partnership with Los Angeles Lakers star Danny Green to motivate the world in recognizing sleep as key to overall health and wellness, equal to physical fitness. The partnership features Green in Eight Sleep's new national advertising campaign, 'Sl

LAVAL, QC and GOSSELIES, Belgium, March 4, 2020 /PRNewswire/ - Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing of a definitive agreement, subject to conditions precedent, to acquire ImmunXperts. The closing of the transaction is expected by

TEL AVIV, Israel, March 4, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology that enables the functional selection of stem cells, today announced that its Board of Directors has approved, and the company has entered, subject to definitive agreements, into a commercial binding Letter Of Intent (LOI) with Canndoc Ltd, a le

SALT LAKE CITY, March 4, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate

SALT LAKE CITY, March 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration ("FDA") acknowledged receipt of the resubmission of TLANDO New Drug Application ("NDA"), the Company's oral testosterone product candidate for testosterone replacement therapy ("TRT") in ad

NEW YORK, March 4, 2020 /PRNewswire/ -- The National Kidney Foundation (NKF) and CVS Kidney Care, a CVS Health company, are partnering on a national campaign to raise awareness about kidney disease which affects approximately 37 million people in the U.S.  In addition, 1 in every 3 American adults, or 33%, are at risk for developing this life-threatening disease. &n

BETHESDA, Md., March 4, 2020 /PRNewswire/ -- Sarah H. Elsea, PhD, FACMG, professor of molecular and human genetics at Baylor College of Medicine and senior director of biochemical genetics at Baylor Genetics, has been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine. The ACMG Foundation i